The global ultrasound gels market was worth USD 89.7 million in 2019 and is predicted to increase at a CAGR of 3.0% from 2020 to 2027. To produce a clean image, an aqueous media must be placed between the ultrasonic probe and the skin. In these operations, ultrasound gel is used as an aqueous media that works as a coupling agent. Carbopol, propylene glycol, phenoxyethanol, glycerin, colours, scent, and water are among the ingredients. Depending on the producer, they are formulated in varying amounts and compositions, and the formulations are private. Ultrasound gel is in high demand from healthcare facilities because it is an unavoidable component of an ultrasound scan. As a result, the growing number of ultrasound procedures performed around the world is likely to propel the market forward. Furthermore, the growing use of ultrasound equipment in point-of-care diagnostics and bedside monitoring will propel the market forward.
The introduction of superior ultrasonic gel with enhanced properties such as odourless, colourless, formaldehyde-free, and glycerin-free is predicted to boost market growth significantly. For example, Parker Laboratories' Aquasonic Clear Ultrasound gel is a colourless and odourless gel with a high coupling efficiency.
In locations with limited access, the use of substances such as guar gum, hand sanitizer, shampoo, cornstarch slurry, lotion, gelatin, betadine, and surgical lube as an alternative to ultrasound gel is projected to restrain market expansion. In addition, the introduction of technologically sophisticated ultrasound probe covers and scan pads that do not require gel is projected to slow market growth.
In 2019, non-sterile ultrasound gel had the highest revenue share (71.0%). During the projected period, the sterile ultrasound gel segment is expected to increase at the fastest rate. External and internal probe methods are two types of ultrasound imaging. External ultrasonic probe operations are done on healthy skin and only require little cleaning and disinfection after each use. For external probe procedures, non-sterile ultrasonic gel is sufficient. As a result, segment expansion will be fueled by the growing number of external probe procedures used to diagnose renal, gallbladder, cancer, and intestinal illnesses.
Commercially accessible sterile ultrasonic gels come in 20ml pocket-sized sachets. They're utilised in ultrasound operations that need sterility, such as treating open wounds and guiding needles. Contamination and the risk of an illness outbreak linked with the use of multi-use nonsterile gel bottles are likely to drive the segment's growth.
In 2019, the hospital segment accounted for 53.5 percent of total revenue and is predicted to rise at a strong CAGR over the projection period. The need for ultrasound gels is predicted to rise as the frequency of emergency room visits for illnesses like acute abdominal pain, chest discomfort, and vascular disorders, where ultrasound is the major diagnostic tool, rises. Furthermore, because gel must be applied each time before inspection, the use of the ultrasound device in follow-up visits will feed the demand curve.
During the forecast period, ambulatory centres and clinics are expected to grow at the fastest rate in the ultrasound gels market. The growing awareness of the value of early intervention in lowering healthcare costs has boosted the number of ultrasound machines installed in clinics. Handheld ultrasound machines are becoming more popular in small clinics due to the low cost of these instruments. As a result, the increased demand for gel in these setups has been aided by the increasing number of ultrasound equipment in clinics.
Comments
Post a Comment